Donor factors and risk of primary graft dysfunction and mortality post lung transplantation: A proposed conceptual framework.

Publication/Presentation Date

12-1-2021

Abstract

Lung transplantation remains a therapeutic option in end-stage lung disease. However, despite advances in the field, early allograft function can be compromised by the development of primary graft dysfunction (PGD); this being the leading cause of morbidity and mortality immediately following the lung transplant procedure. Several recipient factors have been associated with increased risk of PGD, but less is known about donor factors. Aging, tobacco, and chronic alcohol use are donor factors implicated, but how these factors promote PGD remains unclear. Herein, we discuss the available clinical data that link these donor factors with outcomes after lung transplantation, and how they might render the recipient susceptible to PGD through a two-hit process.

Volume

35

Issue

12

First Page

14480

Last Page

14480

ISSN

1399-0012

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

34516007

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS